UNSPSC 51282948: Tosufloxacin

This classification denotes a quinolone antibiotic with the molecular formula C19H15F3N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GHJ553KQPS, chemically known as 1,8-naphthyridine-3-carboxylic acid, 1,4-dihydro-7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo- but generally known as tosufloxacin, which bears US NIH Compound Identifier 5517. European Medicines Agency schedules Tosufloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11201MIG.

UNSPSC 51282948 Tosufloxacin is a Commodity code that nominally identifies a single fluoroquinolone antibiotic product, but recent state and local opportunities show minimal direct activity under this specific code. The recent opportunities posted under this code span pharmaceutical procurement more broadly—including naloxone and drug deactivation systems, first aid supplies for fire rescue operations, and multi-source generic pharmaceuticals and OTC products through cooperative purchasing—rather than solicitations for tosufloxacin itself. State and local buyers posting under this code include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The issuing bodies reflect a mix of direct county and municipal procurement, state-level health agencies, and interstate cooperative vehicles that bundle multiple jurisdictions.

Geographically, recent activity clusters in Florida, Texas, and Minnesota, with Oregon participation through MMCAP. Representative solicitations include Seminole County's IFB for naloxone and drug deactivation systems (posted June 30, 2026; due July 26, 2023—note the date discrepancy in the source), the City of Tampa's IFB for medical and first aid supplies including respiratory equipment and cardiac monitoring supplies for the Tampa Fire Department (due March 13, 2026; estimated contract value $700,000), and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (due March 26, 2026). The MMCAP solicitation emphasizes manufacturer participation through three authorized wholesalers with specific pricing, NDC, and compliance requirements. The code shows little specific procurement of tosufloxacin; vendors pursuing this code should recognize that state and local agencies tag pharmaceutical and medical-supply buys at this Commodity level but actual procurement spans a much broader array of drugs and medical consumables, suggesting the code captures only a small portion of relevant opportunities.